日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Integrative analysis of Trichosanthes kirilowii maxim formula granules' anti-triple-negative breast cancer mechanism via network pharmacology, metabolomics, and molecular pharmacology

通过网络药理学、代谢组学和分子药理学对栝楼特方颗粒抗三阴性乳腺癌机制进行整合分析

Gao, Yuzhen; Lu, Yan; Liu, Yaping; Liu, Fen; Zhang, Jiaqi; Xu, Fei; Ji, Zongwen; Fu, Tian; Shi, Shulong; Jiang, Shulong

DNMT3A p.R882C driven proliferation and anti-apoptotic effects in pancreatic cancer cells

DNMT3A p.R882C 驱动胰腺癌细胞增殖并发挥抗凋亡作用

Qu, Zhen; Mao, Jinglin; Qian, Yang; Cao, Jingyu; Jiang, Shulong

Clinical characteristics and molecular evolution of ST11-KL64 carbapenem-resistant hypervirulent Klebsiella pneumoniae co-producing KPC-2 and NDM-1 from China

中国分离的ST11-KL64型碳青霉烯耐药高毒力肺炎克雷伯菌(同时产生KPC-2和NDM-1)的临床特征和分子进化

Letian Xia #,Mengjiao Shi #,Chenfei Li #,Yaqi Zhu,Fei Jiang,Shulong Zhao,Shuang Song,Youzhen Ma,Lei Cheng,Haiquan Kang

Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function

AMPK对EZH2的磷酸化抑制PRC2甲基转移酶活性及其致癌功能

Wan, Lixin; Xu, Kexin; Wei, Yongkun; Zhang, Jinfang; Han, Tao; Fry, Christopher; Zhang, Zhao; Wang, Yao Vickie; Huang, Liyu; Yuan, Min; Xia, Weiya; Chang, Wei-Chao; Huang, Wen-Chien; Liu, Chien-Liang; Chang, Yuan-Ching; Liu, Jinsong; Wu, Yun; Jin, Victor X; Dai, Xiangpeng; Guo, Jianfeng; Liu, Jia; Jiang, Shulong; Li, Jin; Asara, John M; Brown, Myles; Hung, Mien-Chie; Wei, Wenyi

Comprehensive profiling of lipid metabolic reprogramming expands precision medicine for HCC.

对脂质代谢重编程进行全面分析,可扩大肝细胞癌精准医疗的应用

Liu Qingbin, Zhang Xiangyu, Qi Jingjing, Tian Xinchen, Dovjak Eva, Zhang Jiaqi, Du Honghuan, Zhang Ni, Zhao Jing, Zhang Yiming, Wang Lijuan, Wei Yangang, Liu Chenqiao, Qian Ruikun, Xiang Longquan, Li Weiyang, Xiu Peng, Ma Changlin, Yu Yong, Jiang Shulong

Targeting tumor-associated macrophages to overcome immune checkpoint inhibitor resistance in hepatocellular carcinoma

靶向肿瘤相关巨噬细胞以克服肝细胞癌的免疫检查点抑制剂耐药性

Liu, Fen; Li, Xianying; Zhang, Yiming; Ge, Shan; Shi, Zhan; Liu, Qingbin; Jiang, Shulong

Lactate-mediated metabolic reprogramming of tumor-associated macrophages: implications for tumor progression and therapeutic potential

乳酸介导的肿瘤相关巨噬细胞代谢重编程:对肿瘤进展和治疗潜力的影响

Jin, Xiaohan; Zhang, Ni; Yan, Tinghao; Wei, Jingyang; Hao, Lingli; Sun, Changgang; Zhao, Haibo; Jiang, Shulong

m6A epitranscriptomic modification in hepatocellular carcinoma: implications for the tumor microenvironment and immunotherapy

肝细胞癌中m6A表观转录组修饰:对肿瘤微环境和免疫治疗的影响

Liu, Fen; Liu, Qingbin; Li, Xianying; Wang, Yufei; Cao, Ruoyu; Zhang, Shiyu; Jiang, Shulong; Wu, Jianlin

Mechanistic Exploration of Shugan Jianpi Formula for Treating Triple-Negative Breast Cancer Under Chronic Stress: A Network Pharmacology-Guided Experimental Study.

疏肝健脾方治疗慢性应激下三阴性乳腺癌的机理探索:一项基于网络药理学的实验研究

Liu Fen, Li Luning, Zhang Yiming, Zhang Jiaqi, Tian Xinchen, Zhang Dengtian, Zhang Ni, Yan Tinghao, Shi Shulong, Wu Jianlin, Jiang Shulong

Reversal of sorafenib resistance in hepatocellular carcinoma by curcumol: insights from network pharmacology, molecular docking, and experimental validation

姜黄醇逆转肝细胞癌索拉非尼耐药性:来自网络药理学、分子对接和实验验证的启示

Zhang, Ni; Tian, Xinchen; Liu, Fen; Jin, Xiaohan; Zhang, Jiaqi; Hao, Lingli; Jiang, Shulong; Liu, Qingbin